AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 291 min read$GBTG

Crawley Andrew George sold (to issuer) 1,054,077 shares of GBTG

Crawley Andrew George (President) sold (to issuer) 1,054,077 shares of Global Business Travel Group, Inc. (GBTG) across 3 trades on 2026-09-29.

Original reporting
SEC EDGAR · Crawley Andrew George
Published Sep 29, 2026, 8:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$GBTG
Bearish
medium confidence
Mentioned
$GBTG
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GBTGBearishLow
01

Why it matters

The filing provides fresh, primary information about insider holdings, which can influence short-term trading decisions.

02

Market read

Insider sell of over a million shares by the president is a material event for GBTG investors.

03

What to watch

Absence of price information and possible pre-arranged sale plan may mitigate negative impact.

Relevance 6/10Novelty 7/10Timing: same-day filing

Background

SEC Form 4 filing discloses insider transactions required by regulation.

Company-level read

Ticker impact

$GBTGBearishMedium confidence
Context

President Andrew George Crawley sold 1,054,077 shares of Global Business Travel Group in a Form 4 filing, reducing his stake to zero.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A senior officer disposing of over a million shares suggests reduced confidence; no price disclosed, but the volume is material.

Market effects

Sector

Travel and corporate expense management sector may see heightened scrutiny of insider activity.

Regional

U.S. market participants may adjust exposure to GBTG.

Global

Limited to the company's shareholders and sector; no broader macro effect.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event unrelated to company fundamentals.

Key entities

  • Company
    Global Business Travel Group, Inc.

    U.S.-listed travel management firm (NASDAQ: GBTG).

  • Executive
    Andrew George Crawley

    President of GBTG who sold his entire shareholding.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

GBTG insider trading history →

Related articles

OCT 2
$HRLMedAI 8/10

Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankrupt

Hormel (HRL) acquires Brakebush for $1.06B; Onsemi (ON) to buy Synaptics for $5.7B; Leslie's files for bankruptcy. Valley National (VLY) to acquire Bluevine for $340M. Yext (YEXT) to acquire Flamel.ai. Lifecore (LFCR) to be acquired by Webster Equity for up to $663.7M. SoftBank completes DigitalBridge acquisition. GBTG acquired by Long Lake for $6.3B.

benzinga.com3 min
SEP 11
$INTUMed

Q2 Earnings Highs And Lows: Intuit (NASDAQ:INTU) Vs The Rest Of The Finance and HR Software Stocks

Intuit (INTU) reported Q2 revenue of $4.35B, up 13.7% YoY, but missed EPS guidance, causing shares to drop 12.5%. American Express Global Business Travel (GBTG) saw 37.9% revenue growth, beating estimates. Marqeta (MQ) reported $176M revenue, up 17% YoY, but missed guidance. Paylocity (PCTY) beat estimates with 11% growth. BlackLine (BL) reported $187.8M revenue, in line with expectations but down 13.2% post-earnings.

yahoo.com3 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min